LoginSignup
OLY

Olympus ADR

Stock
Stock
ISIN: US68163W2089
Ticker: OLYMY
US68163W2089
OLYMY

Price

Price

CHART BY

Frequently asked questions

What is Olympus ADR's market capitalization?

The market capitalization of Olympus ADR is $89.69M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Olympus ADR's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Olympus ADR is 17.02. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Olympus ADR?

Olympus ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.004695. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Olympus ADR's stock?

Currently, 13 analysts cover Olympus ADR's stock, with a consensus target price of $0.107. Analyst ratings provide insights into the stock's expected performance.

What is Olympus ADR's revenue over the trailing twelve months?

Over the trailing twelve months, Olympus ADR reported a revenue of $45.24M.

What is the EBITDA for Olympus ADR?

Olympus ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $11.55M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Olympus ADR?

Olympus ADR has a free cash flow of $6.53M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Olympus ADR have, and what sector and industry does it belong to?

Olympus ADR employs approximately 29,297 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

Financials

Market Cap 
$89.69M
EPS (TTM) 
0.004695
P/E ratio (TTM) 
17.02
Revenue (TTM) 
$45.24M
EBITDA (TTM) 
$11.55M
Free Cashflow (TTM) 
$6.53M

Analyst Ratings

The price target is $0.107 and the stock is covered by 13 analysts.

Buy

8

Hold

5

Sell

0

Information

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Employees
29,297
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US68163W2089
Primary Ticker
OLYMY

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin